Holt Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,007
| Closed | -$208K | – | 154 |
|
|
2023
Q1 | $208K | Hold |
3,007
| – | – | 0.04% | 153 |
|
|
2022
Q4 | $216K | Hold |
3,007
| – | – | 0.04% | 153 |
|
|
2022
Q3 | $214K | Sell |
3,007
-800
| -21% | -$56.9K | 0.06% | 140 |
|
|
2022
Q2 | $293K | Hold |
3,807
| – | – | 0.06% | 129 |
|
|
2022
Q1 | $278K | Hold |
3,807
| – | – | 0.05% | 142 |
|
|
2021
Q4 | $237K | Hold |
3,807
| – | – | 0.04% | 156 |
|
|
2021
Q3 | $225K | Sell |
3,807
-100
| -3% | -$5.91K | 0.04% | 151 |
|
|
2021
Q2 | $261K | Sell |
3,907
-100
| -2% | -$6.68K | 0.05% | 144 |
|
|
2021
Q1 | $253K | Hold |
4,007
| – | – | 0.05% | 139 |
|
|
2020
Q4 | $249K | Buy |
+4,007
| New | +$249K | 0.06% | 135 |
|
|
2016
Q2 | – | Sell |
-1,800
| Closed | -$115K | – | 138 |
|
|
2016
Q1 | $115K | Buy |
+1,800
| New | +$115K | 0.05% | 139 |
|
|
2015
Q4 | – | Sell |
-1,800
| Closed | -$107K | – | 122 |
|
|
2015
Q3 | $107K | Hold |
1,800
| – | – | 0.04% | 130 |
|
|
2015
Q2 | $120K | Hold |
1,800
| – | – | 0.05% | 133 |
|
|
2015
Q1 | $116K | Hold |
1,800
| – | – | 0.05% | 133 |
|
|
2014
Q4 | $106K | Buy |
+1,800
| New | +$106K | 0.05% | 139 |
|
|
2014
Q3 | – | Sell |
-1,700
| Closed | -$82K | – | 118 |
|
|
2014
Q2 | $82K | Hold |
1,700
| – | – | 0.04% | 129 |
|
|
2014
Q1 | $88K | Hold |
1,700
| – | – | 0.05% | 114 |
|
|
2013
Q4 | $90K | Buy |
+1,700
| New | +$90K | 0.06% | 108 |
|